Potent Myostatin Inhibitor & SARM
Dragon Pharma YK-11 10 mg, known pharmaceutically as Myostine, represents a revolutionary frontier in performance enhancement, blurring the lines between a Selective Androgen Receptor Modulator (SARM) and a true myostatin inhibitor. This unique dual-action compound is engineered for the advanced athlete who seeks to push beyond the natural genetic limits of muscle hypertrophy. YK-11's primary claim to fame is its ability to directly inhibit myostatin, a protein that acts as the body's master regulator to suppress excessive muscle growth. By blocking this natural "brake," YK-11 creates a physiological environment conducive to extraordinary muscle development, potentially increasing both the size (hypertrophy) and number (hyperplasia) of muscle fibers.
Produced in Dragon Pharma's EU-certified facilities, each 10 mg tablet offers a precise and potent dose of this powerful research compound. Beyond myostatin inhibition, YK-11 also functions as a partial agonist of the androgen receptor, selectively promoting anabolic activity in muscle and bone tissue. This synergy can result in rapid, dry lean mass gains, dramatic increases in strength and power, and significant fat loss, all while aiming to minimize androgenic side effects on non-target tissues like the prostate and skin. The gains from YK-11 are often described as "3D" – dense, hard, and full, with pronounced vascularity, making it a favorite during recomping or lean bulk phases.
It is crucial to understand that YK-11's potency comes with significant responsibility. It is one of the most suppressive SARMs, severely impacting the HPTA (Hypothalamic-Pituitary-Testicular Axis) and necessitating a strict Post Cycle Therapy (PCT). Furthermore, its unique mechanism can lead to joint stiffness, as connective tissues may struggle to adapt to rapidly increasing strength. Therefore, this product is unequivocally recommended only for experienced users with a foundation of cycle knowledge and a commitment to comprehensive on-cycle support and post-cycle recovery protocols.
Key Benefits:
Each sachet contains 100 tablets of 10mg Myostine (YK-11), manufactured under strict quality control standards in Dragon Pharma's certified facilities.
| Product Name | YK-11 10 mg |
| Manufacturer | Dragon Pharma |
| Substance | Myostine (YK-11) |
| Packaging | 100 tablets in sealed sachet |
| Lab Test Result | 9.29 mg (April 2025) |
| Half-Life | Approximately 6 - 12 hours |
| Recommended Cycle | 6 - 8 weeks maximum |
| Form | Oral tablet |
| Aromatization | No (Non-estrogenic, but highly suppressive) |
| Dosage (Men) | 5 - 15 mg per day (split doses) |
Warning: YK-11 is an advanced, highly suppressive compound. These guidelines are for informational purposes. Blood work before, during, and after a cycle is strongly advised. Always have your PCT (Post Cycle Therapy) compounds on hand before starting. Consider using a testosterone base (like Testabol 400) to combat severe suppression during longer or higher-dose cycles.
Begin PCT 24 hours after your last YK-11 dose. Due to extreme suppression, a robust 4-6 week PCT is non-negotiable. A typical protocol: Weeks 1-2: Clomid 50mg/day or Nolvadex 40mg/day. Weeks 3-4: Clomid 25mg/day or Nolvadex 20mg/day. Consider extending at a lower dose for weeks 5-6 if blood work shows slow recovery. A product like HCG can be used in a blast before starting SERMs, but this requires precise timing.
While not severely hepatotoxic, YK-11 still adds metabolic stress. Use a comprehensive liver support supplement (NAC, TUDCA, Milk Thistle). Pay close attention to joint health: supplement with Omega-3s, Cissus Quadrangularis, and Glucosamine. Monitor blood pressure and cholesterol regularly. A heart-healthy diet, cardio, and supplements like Citrus Bergamot or Fish Oil are essential.
Note: Independent lab testing verifies the active substance content per tablet, ensuring you receive a genuine, accurately dosed Dragon Pharma product. The April 2025 result of 9.29 mg per tablet confirms product purity and consistency.
To preserve the integrity, potency, and shelf life of your Dragon Pharma YK-11 (Myostine) tablets, please follow these storage protocols:
YK-11, known as Myostine, serves two primary functions: it acts as a potent myostatin inhibitor and a selective androgen receptor modulator (SARM). As a myostatin inhibitor, it blocks the myostatin protein, a natural limiter of muscle growth, potentially allowing for exceptional muscle hyperplasia (increase in muscle fiber number) and hypertrophy (increase in muscle fiber size). Concurrently, its SARM activity selectively binds to androgen receptors in muscle and bone, promoting anabolism, strength, and fat loss without extensive androgenic side effects in other tissues.
Common side effects of YK-11 can include significant suppression of natural testosterone production, requiring Post Cycle Therapy (PCT). Users may also experience androgenic side effects like hair loss or acne (in predisposed individuals), joint stiffness or dry joints, and potential negative impacts on cholesterol (lowering HDL, raising LDL). Due to its unique mechanism, there is also a theoretical risk of tendon strength not keeping pace with rapid muscle gains, increasing injury risk. Proper dosing, cycle length, and on-cycle support are crucial to mitigate these effects.
Yes, research indicates that YK-11 functions as a genuine myostatin inhibitor. It achieves this by binding to and blocking the activity of the myostatin protein, which is a key negative regulator of muscle growth. By inhibiting myostatin, YK-11 removes a natural 'brake' on muscle development, potentially leading to the kind of extreme muscle growth seen in animals and humans with genetic myostatin deficiencies. This dual-action as both a myostatin inhibitor and a SARM is what makes YK-11 a uniquely powerful compound in the performance enhancement category.
Standard workplace or sports drug tests typically screen for common narcotics, amphetamines, and specific banned substances like traditional anabolic steroids. YK-11, being a research chemical/SARM, is not usually included in these standard panels. However, it is banned by major sports organizations like WADA. Specialized SARM tests or advanced mass spectrometry screening can detect it. Athletes subject to competitive testing should assume YK-11 is detectable and prohibited.
YK-11 is considered qualitatively different and often regarded as more powerful in terms of its pure muscle-building potential due to its unique myostatin inhibition. While SARMs like LGD-4033 (Ligandrol) are potent anabolic agents, they work primarily through the androgen receptor. YK-11 adds a second, profound mechanism by blocking myostatin. This can lead to a different quality of gains—potentially more extreme and with a focus on hyperplasia. However, this also comes with a potentially higher risk of side effects, especially suppression and joint issues, making it a compound best suited for experienced users.